Education
About Us
Working with TipRanks
Follow Us
Spectral Medical (TSE:EDT)
TSX:EDT
EDT Stock Chart & Stats
C$1.58
-C$0.01(-1.75%)
At close: 4:00 PM EST
C$1.58
-C$0.01(-1.75%)
Day’s Range― - ―
52-Week RangeC$0.46 - C$1.84
Previous CloseN/A
Volume37.78K
Average Volume (3M)115.81K
Market Cap
$440.56M
Enterprise ValueC$245.19M
Total Cash (Recent Filing)$3.10M
Total Debt (Recent Filing)$17.60M
Price to Earnings (P/E)―
Beta0.61
Next Earnings
Nov 07, 2025EPS Estimate
-0.01Last Dividend Ex-Date
Dec 19, 2011Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding287,944,950
10 Day Avg. Volume85,727
30 Day Avg. Volume115,814
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.56
Enterprise Value/Revenue96.84
Enterprise Value/Gross Profit161.84
Enterprise Value/Ebitda-14.51
Forecast
1Y Price Target
$1.00Price Target Upside-36.99% Downside
Rating ConsensusHold
Number of Analyst Covering0
Spectral Medical News
EDT FAQ
What was Spectral Medical’s price range in the past 12 months?
Spectral Medical lowest stock price was C$0.46 and its highest was C$1.84 in the past 12 months.
What is Spectral Medical’s market cap?
Spectral Medical’s market cap is $440.56M.
When is Spectral Medical’s upcoming earnings report date?
Spectral Medical’s upcoming earnings report date is Nov 07, 2025 which is in 17 days.
How were Spectral Medical’s earnings last quarter?
Spectral Medical released its earnings results on Aug 08, 2025. The company reported C$0 earnings per share for the quarter, the consensus estimate of N/A by C$0.
Is Spectral Medical overvalued?
According to Wall Street analysts Spectral Medical’s price is currently Overvalued.
Does Spectral Medical pay dividends?
Spectral Medical pays a Notavailable dividend of C$0.12 which represents an annual dividend yield of N/A. See more information on Spectral Medical dividends here
What is Spectral Medical’s EPS estimate?
Spectral Medical’s EPS estimate is -0.01.
How many shares outstanding does Spectral Medical have?
Spectral Medical has 287,944,950 shares outstanding.
What happened to Spectral Medical’s price movement after its last earnings report?
Spectral Medical reported an EPS of C$0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went down -1.22%.
Which hedge fund is a major shareholder of Spectral Medical?
Currently, no hedge funds are holding shares in TSE:EDT
Company Description
Spectral Medical
Spectral Medical Inc., together with its subsidiaries, focuses on the development and commercialization of products for the treatment of septic shock and renal disease in North America. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies; and develops platform for renal replacement therapy. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.
Technical Analysis
Arch Biopartners
―
Medicenna Therapeutics Corp
―
Eastwood Bio-Medical Canada
―
Medexus Pharmaceuticals Inc
―
Profound Medical
―
Options Prices
Currently, No data available
---